✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)
ALVEOLE
Limited liability company (SARL) · RC 795407113 · Active since 2013
Overview
ALVEOLE is a limited liability company (sarl) registered in France, since 2013. The company operates in the financial services sector. With reported revenue of 70K EUR in 2017. Its TraceComp score of 78 (B+) indicates solid fundamentals and low apparent risk. With 12 years of operations, the company has an established track record in its market.
Company Information
- Registration Number
- 795407113
- Legal Form
- Limited liability company (SARL)
- Registered
- 2013-09-20
Financial Profile
Latest filed accounts: FY 2017 · most recent available in public filings
Multi-year financials & ratios
1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Officers & Management
1 officer/director on file — names, roles, appointment & resignation dates.
| Name | Role | Status |
|---|---|---|
| STEPHANE ALBERT DROUOT | Manager (gérant) | Current |
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Research Output
Active research organization. 25 publications · 735 citations · h-index 9 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Medicine (48%) · Engineering (24%) · Biochemistry, Genetics and Molecular Biology (21%).
See full research profile — top researchers & publications →
Source: OpenAlex (CC0). Objective publication & citation counts.
Patent Portfolio
Active patent holder. 3 patents · 3 active · 3 granted in the USPTO/EPO record.
See full patent portfolio — most-cited inventions & inventors →
Source: USPTO / EPO open patent data. Objective bibliographic counts.
Risk Signals
No adverse legal events have been recorded for this company.
- Net loss reported in FY 2017
- Altman Z-Score in the safe zone
Data Sources & Freshness
Data sourced from: bulk register.